Summary
Three chemical classes of serotonin 5-HT4 receptor agonists have been identified so far: 5-substituted indoles (e.g. 5-HT), benzamides (e.g. renzapride) and benzimidazolones (e.g. BIMU 8). In a search for 5-HT4 receptor antagonists, we have discovered that the benzimidazolone derivative DAU 6285 (for structure see text), is 3–5 times more potent than tropisetron in blocking 5-HT, renzapride and BIMU 8 induced stimulation of adenylate cyclase activity in mouse embryo colliculi neurons. Schild plot analysis yielded Ki values of 220, 181 and 255 nmol/l, respectively. In addition, DAU 6285 showed poor activity as a 5-HT3 receptor ligand with respect to tropisetron, as demonstrated by in vitro binding studies (Ki, 322 vs 2.8 nmol/l) and by its antagonistic activity in the Bezold-Jarisch reflex test (ID50, 231 vs 0.5 μg/kg, i.v.). No significant binding (Ki>10 μmol/l) of DAU 6285 to serotonergic 5-HT1A, 5-HT1B, 5-HT1C, 5-HT1D, and 5-HT2 receptors as well as to adrenergic α1, α2, dopaminergic D1, D2 or muscarinic M1–M3 receptor subtypes was found. The data indicate that DAU 6285 has a somewhat higher affinity than tropisetron for 5-HT4 receptors, a property confirmed in functional tests, and much lower affinity than tropisetron for 5-HT3 receptors. The compound represents a new interesting tool for investigating the pharmacological and physiological properties of 5-HT4 receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58
Baxter GS, Craig DA, Clarke DE (1991) 5-hydroxytryptamine 4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae. Naunyn-Schmiedeberg's Arch Pharmacol 343:439–446
Billard W, Ruperto V, Crosby G, Iorio LC, Barnett A (1984) Characterisation of the binding of [3H]-SCH 23390, a selective D1 receptor antagonist ligand in rat striatum. Life Sci 35:1885–1893
Bockaert J, Sebben M, Dumuis A (1990) Pharmacological characterization of 5-HT4 receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: Effect of substituted benzamide derivatives. Mol Pharmacol 37:408–411
Bolanos FJ, Schechter LE, Miquel MC, Emerit MB, Rumigny JF, Hamon M, Gozlan H (1990) Common pharmacological and physicochemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG-108–15 cloned cells. Biochem Pharmacol 40:1541–1550
Borsini F, Templeton D, Turconi M, Nicola M, Schiantarelli P, Donetti A (1990) Anxiolytic effects of a new structural class of 5-HT3 antagonists. Psychopharmacology 101:57
Buchheit KH, Engel G, Mutschler E, Richardson BP (1985) Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea pig ileum. Evidence for two distinct release mechanisms. Naunyn-Schmiedeberg's Arch Pharmacol 329:36–41
Buchheit KH, Gamse R (1991) SDZ 205-557 a new antagonist for 5 HT4 receptors in the isolated guinea pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 343 [Suppl]:402P
Buchheit KH, Gamse R, Pfannkuche HJ (1991) SDZ 205–557, a selective antagonist at 5-HT4 receptors in the isolated guinea pig ileum. Eur J Pharmacol 200:373–374
Clarke DE, Craig DA, Fozard JR (1989) The 5-HT4 receptor: naughty, but nice. Trends Pharmacol Sci 10:385–386
Craig DA, Clarke DE (1989) 5-Hydroxytryptamine and cholinergic mechanisms in guinea pig ileum. Br J Pharmacol 96:247P
Craig DA, Clarke DE (1990) Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-HT4 receptor. J Pharmacol Exp Ther 252:1378–1386
Craig DA, Eglen RM, Walsh LKM, Perkins LA, Whiting RL, Clarke DE (1990) 5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine induced desensitization as discriminative tools for the 5-HT3 and putative 5-HT4 receptors in guinea pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 342:9–16
Creese I, Burt DR, Snyder SH (1975) Dopamine receptor binding: differenciation of agonist and antagonist states with [3H]-dopamine and [3H]-haloperidol. Life Sci 17:933–1001
Dumuis A, Bouhelal R, Sebben M, Bockaert J (1988a) A 5-HT receptor in the central nervous system positively coupled with adenylate cyclase is antagonized by ICS 205–930. Eur J Pharmacol 146:187–188
Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J (1988b) A non classical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34:880–887
Dumuis A, Sebben M, Bockaert J (1989a) BRL 24924, a potent agonist at a non classical 5-HT receptor positively coupled with adenylate cyclase in colliculi neurons. Eur J Pharmacol 162:381–384
Dumuis A, Sebben M, Bockaert J (1989b) The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate acylase in neurons. Naunyn-Schmiedeberg's Arch Pharmacol 340:403–410
Dumuis A, Sebben M, Monferini E, Nicola M, Ladinsky H, Bockaert J (1991) Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain. Naunyn-Schmiedeberg's Arch Pharmacol 343:245–251
Eglen RM, Swank SR, Walsh LK, Whiting RL (1991) Characterisation of 5-HT receptors mediating contractions in guinea-pig ileum in vitro. Br J Pharmacol 99:216P
Elswood CJ, Bunce KT, Humphrey PPA (1991) Identification of putative 5-HT4 receptors in guinea pig ascending colon. Eur J Pharmacol 196:149–155
Fozard JR (1984) MDL 72222: A potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 326:36–41
Greenberg DA, Prichard DC, Snyder SH (1976) α-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist stated. Life Sci 19:69–76
Greengrass P, Bremmer R (1979) Binding characteristics of [3H] prazosin to rat brain α-adrenergic receptors. Eur J Pharmacol 55:323–326
Gozlan H, Daval G, Verge D, Spampinato U, Fattaccini CM, Gallissot MC, El Mestikawy S, Hamon M (1990) Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain. Neurobiol Aging 11:437–449
Hammer R, Giraldo E, Schiavi GB, Monferini E, Ladinsky H (1986) Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116 to membranes of peripheral tissues and brain in the rat. Life Sci 38:1653–1662
Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1990) A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol 100:879–885
Kaumann AJ (1990) Piglet sinoatrial 5-HT receptors resemble human atrial 5-HT4-like receptors. Naunyn-Schmiedeberg's Arch Pharmacol 342:619–622
McPherson GA (1985) Kinetic, EBDA, ligand, Lowry: A collection of radioligand binding analysis programs. Elsevier Biosoft, Cambridge, UK
Ouadid H, Seguin J, Frapier JM, Dumuis A, Bockaert J, Nargeot J (1991) 5-hydroxytryptamine increases CA++ current in human atrial cells via a 5-HT4 receptor positively coupled to adenylate cyclase. J Physiol (Lond) 435:93P
Reeves JJ, Bunce KT, Humphrey PPA (1991) Investigation of the 5-hydroxytryptamine receptor mediatin smooth muscle relaxation in the rat oesophagus. Br J Pharmacol 102:1067–1072
Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature (London) 316:126–131
Rizzi CA, Onori L, Sanguini AM, Coccini T, Tonini M (1990) Facilitation of cholinergic transmission and peristalsis induced by a novel class of benzimidazolone derivatives in the guinea-pig small intestine. Abstract of the Secon IUPHAR satellite meeting on Serotonin 152P
Sanger GJ (1987a) Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924. Br J Pharmacol 91:77–87
Sanger GJ (1987b) Activation of a myenteric 5-hydroyxytryptamine-like receptor by metoclopramide. J Pharm Pharmacol 39:449–453
Schiantarelli P, Bockaert J, Cesana R, Donetti A, Dumuis A, Giraldo E, Ladinsky H, Monferini E, Rizzi C, Sagrada A, Schiavone E (1990) The prokinetic properties of new benzimidazolone derivatives are related to 5-HT4 agonism. Pharmacol Res 22 [Suppl 2]:453
Schiavone A, Cesana R, Micheletti R, Rizzi CA, Turconi M, Nicola M, Schiantarelli P, Donetti A (1990) Prokinetic activity of a novel non benzamidic compound. Abstract of the Second IUPHAR satellite meeting on Serotonin 153P
Schiavone A, Giraldo E, Giudici L, Turconi M (1991) DAU 6285: A novel 5-HT4, receptor antagonist. Abstract of the meeting Serotonin 1991, Birmingham 14–17 July
Smith WW, Sancilio LF, Owera-Atepo JB, Naylor RJ, Lambert L (1988) Zacopride, a potent 5-HT3 antagonist. J Pharm Pharmacol 40:301–302
Tonini M, Rizzi CA, Manzo L, Onori L (1991) Novel enteric 5-HT4 receptors and gastrointestinal prokinetic action. Pharmacol Res (in press)
Turconi M, Nicola M, Gil Quintero M, Maiocchi L, Micheletti R, Giraldo R, Donetti A (1990) Synthesis of a new class of 2–3 dihydro-2-oxo-1-H-benzamidazolone-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonists. J Med Chem 33:2101–2108
Turconi M, Donetti A, Schiavone A, Sagrada A, Montagna E, Nicola M, Cesana R, Rizzi CO, Micheletti R (1991) Pharmacological properties of a novel class of 5-HT3 receptor antagonists. Eur J Pharmacol (in press)
Villalòn CM, den Boer MO, Heiligers JPC, Saxena PR (1990) Mediation of 5-hydroxytryptamine induced tachycardia in the pig by the putative 5-HT4 receptor. Br J Pharmacol 100:665–667
Villalòn CM, den Boer MO, Heiligers JPC, Saxena PR (1991) Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig. Br J Pharmacol 102:107–112
Waeber C, Schoeffter P, Palacios JM, Hoyer D (1989) 5-HT1D receptors in guinea pig and pigeon brain. Radioligand binding and biochemical studies. Naunyn-Schmiedeberg's Arch Pharmacol 340:479–485
Weiss S, Pin JP, Sebben M, Kemp DE, Sladeczek F, Gabrion J, Bockaert J (1986) Synaptogenesis of cultured striatal neurons in serum-free medium: A morphological and biochemical study. Proc Natl Acad Sci USA 83:2238–2242
Author information
Authors and Affiliations
Additional information
Send offprint requests to A. Dumuis at the above address
Rights and permissions
About this article
Cite this article
Dumuis, A., Gozlan, H., Sebben, M. et al. Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. Naunyn-Schmiedeberg's Arch Pharmacol 345, 264–269 (1992). https://doi.org/10.1007/BF00168685
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168685